home / stock / cydy / cydy short
Short Information | CytoDyn Inc (OTCMKTS:CYDY)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 15,760,992 |
Total Actual Volume | 49,783,988 |
Short Trends | |
---|---|
Cover Days | 14 |
Short Days | 4 |
No Change Days | 2 |
Averages | |
---|---|
Average Short Volume | 788,050 |
Average Short Percentage | 33.74% |
Is there a CYDY Short Squeeze or Breakout about to happen?
See the CYDY Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-03-2024 | $0.14 | $0.13575 | $0.143 | $0.1321 | 2,042,396 | 237,887 | 11.65% |
07-02-2024 | $0.1376 | $0.13635 | $0.1399 | $0.134 | 655,121 | 174,939 | 26.7% |
07-01-2024 | $0.137 | $0.1376 | $0.144 | $0.1351 | 670,333 | 209,982 | 31.33% |
06-28-2024 | $0.1499 | $0.139 | $0.15 | $0.131243 | 3,337,139 | 458,162 | 13.73% |
06-27-2024 | $0.14975 | $0.14875 | $0.15 | $0.1476 | 1,255,585 | 913,623 | 72.76% |
06-26-2024 | $0.1399 | $0.145125 | $0.157 | $0.1362 | 2,576,878 | 1,225,584 | 47.56% |
06-25-2024 | $0.14 | $0.1375 | $0.1474 | $0.1356 | 667,553 | 335,107 | 50.2% |
06-24-2024 | $0.144 | $0.1398 | $0.144 | $0.133 | 631,048 | 246,654 | 39.09% |
06-21-2024 | $0.1479 | $0.14 | $0.1479 | $0.1351 | 379,526 | 121,763 | 32.08% |
06-20-2024 | $0.1371 | $0.1362 | $0.153 | $0.1281 | 3,902,689 | 1,273,411 | 32.63% |
06-18-2024 | $0.131 | $0.134 | $0.139832 | $0.1306 | 1,693,539 | 588,610 | 34.76% |
06-17-2024 | $0.1342 | $0.131 | $0.137 | $0.1275 | 2,881,356 | 596,024 | 20.69% |
06-14-2024 | $0.142 | $0.1341 | $0.142 | $0.1311 | 3,709,408 | 1,903,168 | 51.31% |
06-13-2024 | $0.145 | $0.1369 | $0.1471 | $0.1361 | 2,480,695 | 1,358,261 | 54.75% |
06-12-2024 | $0.145 | $0.1371 | $0.145 | $0.1355 | 3,112,714 | 442,948 | 14.23% |
06-11-2024 | $0.1501 | $0.1403 | $0.1545 | $0.1371 | 9,213,058 | 2,660,864 | 28.88% |
06-10-2024 | $0.1524 | $0.15 | $0.1575 | $0.1441 | 2,369,998 | 646,751 | 27.29% |
06-07-2024 | $0.1564 | $0.15 | $0.164 | $0.1473 | 3,224,228 | 1,024,946 | 31.79% |
06-06-2024 | $0.148 | $0.1526 | $0.1597 | $0.148 | 2,097,190 | 522,072 | 24.89% |
06-05-2024 | $0.147 | $0.1452 | $0.154 | $0.1427 | 2,883,534 | 820,236 | 28.45% |
News, Short Squeeze, Breakout and More Instantly...
VANCOUVER, Washington, June 27, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that its preclinical MASH study with SMC ...
VANCOUVER, Washington, May 28, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Dr. Jacob P. Lalezari, Chief Executiv...
VANCOUVER, Washington, May 16, 2024 (GLOBE NEWSWIRE) -- Dear Shareholders, I write today to provide an update on CytoDyn Inc. (“CytoDyn” or “Company”), as we approach the end of our 2024 fiscal year (May 31, 2024), and to sincerely thank you for your unwavering...